Table 3 Treatment in patients with Mansonella perstans, n/n (proportion, %)
Anti-filarial drugs 437/503 (86.9%) | Adverse effects 25/503 (5%) | Healinga 240/503 (47.7%) | |
|---|---|---|---|
Simple treatment | 292/503 (58.1) | 12/292 (4.1) | 154/292 (52.7) |
Mebendazole | 267/503 (53.1) | 9/267 (3.4) | 152/267 (56.9) |
Ivermectine | 16/503 (3.2) | 2/16 (12.5) | 0 |
Albendazole | 9/503 (1.8) | 1/9 (11.1) | 2/9 (22.2) |
Combined treatment | 145/503 (28.8) | 13/145 (9.0) | 86/145 (59.3) |
Diethylcarbamazcine + Ivermectine + Mebendazole | 20/503 (4.0) | 3/20 (15.0) | 17/20 (85.0) |
Diethylcarbamazcine + Mebendazole | 3/503 (0.6) | 1/3 (33.3) | 3/3 (100.0) |
Diethylcarbamazcine + Albendazole | 5/503 (1.0) | 2/5 (40.0) | 4/5 (80.0) |
Ivermectine + Mebendazole | 113/503 (22.5) | 7/113 (6.2) | 61/113 (54.0) |
Ivermectine + Mebendazole + Albendazole | 1/503 (0.2) | 0 | 0 |
Mebendazole + Albendazole | 3/503 (0.6) | 0 | 1/3 (33.3) |
None/No follow-up | 66/503 (13.1) | 478/503 (95.0) | 263/503 (52.3) |